Peer review reports
From: Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting
Original Submission |
10 Dec 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
1 Feb 2022 |
Reviewed |
Reviewer Report
|
30 Mar 2022 |
Reviewed |
Reviewer Report
|
13 May 2022 |
Author responded |
Author comments - Jean Malacan
|
Resubmission - Version 5 |
13 May 2022 |
Submitted |
Manuscript version 5
|
15 May 2022 |
Author responded |
Author comments - Jean Malacan
|
Resubmission - Version 6 |
15 May 2022 |
Submitted |
Manuscript version 6
|
18 May 2022 |
Author responded |
Author comments - Jean Malacan
|
Resubmission - Version 7 |
18 May 2022 |
Submitted |
Manuscript version 7
|
23 May 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
Publishing |
23 May 2022 |
Editorially accepted |
|
5 Aug 2022 |
Article published |
10.1186/s12874-022-01659-w
|
Learn about peer review